21 aa
Predicted · Cα pLDDT 95.9 / 100
Completion observed (Asia/Shanghai):
Static model
PAE · Å
PAE image is unavailable.
pTM 0.17
A few molecular notes beside a poem.
STARSRISEINASILENTSEA
These model readings are not real-world event rates; suitability for this peptide has not been validated.
Modelled molecular behavior
Each endpoint keeps its own 0–1 model output; these are not cross-endpoint rankings.
Absorption & transport
- Intestinal absorption · HIA
- 0.11
- Oral bioavailability
- 0.28
- Blood–brain barrier · BBB
- 0.22
- P-gp
- 0.36
Metabolism · CYP
Safety-related assays
- Ames assay
- 0.26
- Drug-induced liver injury · DILI
- 0.24
- hERG channel
- 0.56
Reading notes & six additional results
Classification outputs are uncalibrated; they do not establish individual event probabilities or safety.
Method: TabPFN2.5 · tdc22_v1
Result observed at:
Chemical form: linear L-peptide, with free, neutral termini and side chains.
Units and numerical scales for these six endpoints remain unconfirmed; the model readings are retained below.
- Caco-2
- -6.66
- Hepatocyte clearance
- 21.25
- Microsomal clearance
- 53.66
- Half-life
- 13.08
- Plasma protein binding
- 64.03
- Distribution volume
- 0.47
Readings retain the scale returned for each endpoint; no conversion to linear physical quantities has been made. Glyphs identify endpoints, not measurement axes.